KSNW Wichita on MSN
Wichita VA test helps tailor prescriptions to each patient
The Robert J. Dole VA Medical Center has an ace in the hole when it comes to figuring out which medications work best for each veteran it serves.
DPYD, From Guidelines to Go-Live: Implementing Testing in the Lab, Upcoming Webinar Hosted by Xtalks
In this free webinar, see how DPYD testing can be implemented from guidelines to go-live through practical pharmacogenomics (PGx) reporting and workflow design. The featured speakers will share ...
Pharmacogenomics (PGx) is a foundational component of precision medicine, yet many laboratories and health systems continue to face challenges translating PGx evidence into routine clinical ...
Prostate cancer (PC) is a significant health concern, being the second leading cause of death among American men. The standard treatment for advanced PC often involves androgen deprivation therapy ...
Pharmacogenomics, the study of how genetic variations influence medication response, is one of the most widely used forms of precision medicine. Understanding a patient’s unique genetic makeup helps ...
- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - Capecitabine and 5-FU are used for the treatment of colorectal, esophageal, stomach, ...
STONY BROOK, NY / ACCESSWIRE / June 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a global leader in PCR-based DNA technologies, today announced that its molecular diagnostics ...
STONY BROOK, NY / ACCESSWIRE / June 13, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ("Applied DNA" or the "Company"), a leader in PCR-based DNA technologies, today announced that the New York ...
This viewpoint is to provide and clarify details regarding the business article published on July 3, headlined “Dr. Julie Wharam hopes to bring pharmacogenomics to mainstream Grand Forks region.” Do ...
- Company Revamps Pharmacogenomics Go-To-Market Strategy, Targets Validated PGx Assay Towards Specific Use Cases - STONY BROOK, NY / ACCESS Newswire / April 1, 2025 / Applied DNA Sciences, Inc.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results